# Topiramate

## Trokendi XR 50mg

| 藥物代碼           | OTRO                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Migraine prophylaxis. Epilepsy monotherapy or adjuvant therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 副作用             | CommonDermatologic: Flushing (Pediatric, 5% )Endocrine metabolic: Serum bicarbonate level abnormal (25% to 67% )Gastrointestinal: Loss of appetite (10% to 24% ), Weight decreased (4% to 21% )Immunologic: Infectious disease (2% to 8% )Neurologic: Confusion (3% to 11% ), Dizziness (4% to 25% ), Impaired cognition (2% to 7% ), Impaired psychomotor performance (2% to 13%), Memory impairment (3% to 12% ), Paresthesia (1% to 51% ), Reduced concentration span (2% to 10% ), Somnolence (6% to 29% )Psychiatric: Feeling nervous (4% to 16% ), Mood disorder (4% to 11% )Other: Fatigue (6% to 16% ), Fever (1% to 12% )SeriousDermatologic: Erythema multiforme, Stevens-Johnson syndrome, Toxic epidermal necrolysisEndocrine metabolic: Hyperammonemia (Adolescent, 26% ), Hypohidrosis, Increased body temperature, Metabolic acidosis (Adult, 14% to 44%; pediatric, 9% to 77% )Hepatic: Liver failureNeurologic: Drug-induced encephalopathyOphthalmic: Angle-closure glaucoma, Glaucoma, Myopia, Visual field defect (Epilepsy, 0.1% to 1% )Psychiatric: Suicidal thoughtsRenal: Nephrolithiasis (Adult, 1% to 3% )Other: Withdrawal symptom |
| 禁忌               | Recent alcohol use within 6 hours prior to or 6 hours after topiramate use. Metabolic acidosis with concomitant metformin use.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 孕期用藥建議       | Human (and animal) data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 附帶說明           | [仿單] 對具有生育能力的女性開立 topiramate 時，尤其是考慮以 topiramate 治療通常不會造成永久性傷害或死亡的狀況時，請考慮此藥的效益及風險。 由於可能使胎兒發生口裂（發生於許多女性仍不知自身懷孕的第一孕期），因此應告知所有具有生育能力的女性接受 topiramate 暴露可能使胎兒承受的危險。 正計畫懷孕的女性應獲得相關諮詢，以了解懷孕期間使用 topiramate 的相對風險及效益，且應考慮讓這類患者使用替代性治療選項。                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 附帶說明           | [仿單]Topiramate 可分泌於人乳中【請參閱資料】。哺乳中嬰兒暴露於topiramate 中的影響仍不明。 哺乳對發育和健康的益處，應連同母親在臨床上對TROKENDI XR 的需求， 以及TROKENDI XR 或潛在母體狀況對哺乳中嬰兒可能產生的任何不良反應一併考量。 關於在泌乳期間接受 topiramate 治療的5 名癲癇女性患者的有限資料顯示， 藥物在乳汁中的濃度係與在母體血漿中的濃度相近。                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 注射劑給藥建議途徑 | AC, PC, PO                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 注意事項           | 由三種不同釋放時間的控釋微粒組成,因此管慣者可以拆膠囊使用,但不建議拆膠囊後分次服藥.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

